Nutex Health (US:NUTX) GlobeNewswire News Roomยท2025-09-03 16:51Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Nutex Health Inc. due to allegations of securities law violations, with a deadline for investors to seek lead plaintiff status in a class action lawsuit by October 21, 2025 [3]. Group 1: Allegations Against Nutex - The complaint alleges that Nutex and its executives made false or misleading statements and failed to disclose critical information regarding their financial practices and relationships with third parties [5]. - Specific allegations include that Nutex engaged in a fraudulent scheme with HaloMD to defraud insurance companies, leading to unsustainable revenue claims [5]. - The company is accused of overstating its ability to remediate internal control weaknesses, which resulted in improper accounting for stock-based compensation obligations [5]. Group 2: Market Reaction - Following the release of a short report by Blue Orca Capital, Nutex's stock price fell by $11.18 per share, or 10.05%, closing at $100.01 on July 22, 2025 [7]. - After Nutex announced a delay in filing its Form 10-Q due to accounting adjustments, its stock price dropped further by $18.22 per share, or 16.39%, closing at $92.91 on August 15, 2025 [8]. Group 3: Legal Proceedings - Investors who purchased Nutex securities between August 8, 2024, and August 15, 2025, are encouraged to discuss their legal rights and options with Faruqi & Faruqi [1][3]. - The firm is also seeking information from whistleblowers, former employees, and shareholders regarding Nutex's conduct [10].